Similar articles

• [Initial provisional record of a controlled trial of isoniazid-rifomycin-thiocarlide versus isoniazid-streptomycin-thiocarlide in active pulmonary tuberculosis not yet treated].

  Willa C, Favez G. Willa C, et al. Acta Tuberc Pneumol Belg. 1969;60(3):577-82. Acta Tuberc Pneumol Belg. 1969. PMID: 4906106 Clinical Trial. French. No abstract available.
• [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].

  Freerksen E. Freerksen E. Dtsch Med Wochenschr. 1970 Jan 16;95(3):139-41. Dtsch Med Wochenschr. 1970. PMID: 5411222 German. No abstract available.
• [Treatment of recent pulmonary tuberculosis with combined rifomycin-isoniazid].

  Constans P, Morin Y, Coury C, Bariety M. Constans P, et al. Acta Tuberc Pneumol Belg. 1969;60(3):545-53. Acta Tuberc Pneumol Belg. 1969. PMID: 5371679 French. No abstract available.
• Bacteriologic basis of short-course chemotherapy for tuberculosis.

  Grosset J. Grosset J. Clin Chest Med. 1980 May;1(2):231-41. Clin Chest Med. 1980. PMID: 6794976 Review. No abstract available.
• Outpatient management of tuberculosis.

  McColloster P, Neff NE. McColloster P, et al. Am Fam Physician. 1996 Apr;53(5):1579-94. Am Fam Physician. 1996. PMID: 8623687 Review.